Pages that link to "Item:Q1787000"
From MaRDI portal
The following pages link to A mathematical model of tumor-immune interactions (Q1787000):
Displaying 50 items.
- A cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q305603) (← links)
- Mathematical model of tumor-immune surveillance (Q307632) (← links)
- A mathematical prognosis model for pancreatic cancer patients receiving immunotherapy (Q309128) (← links)
- T model of growth and its application in systems of tumor-immune dynamics (Q356968) (← links)
- A comparison and catalog of intrinsic tumor growth models (Q467740) (← links)
- Mathematical models of tumor-immune system dynamics. Proceedings of the international workshop, Sydney, Australia, January 7--10, 2013 (Q482998) (← links)
- A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy (Q486657) (← links)
- Bifurcation analysis of a delayed mathematical model for tumor growth (Q502046) (← links)
- A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications (Q669039) (← links)
- A model for effects of adaptive immunity on tumor response to chemotherapy and chemoimmunotherapy (Q739265) (← links)
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections (Q745130) (← links)
- Dynamical behavior of combinational immune boost against tumor (Q904579) (← links)
- A mathematical model of tumor-immune evasion and siRNA treatment (Q1430340) (← links)
- Mathematical modelling of the competition between tumors and immune system considering the role of the antibodies (Q1433135) (← links)
- Modelling and mathematical problems related to tumor evolution and its interaction with the immune system (Q1585820) (← links)
- Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: implications for therapeutic targeting strategies (Q1649405) (← links)
- An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol (Q1680709) (← links)
- Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma (Q1712827) (← links)
- A two-phenotype model of immune evasion by cancer cells (Q1714296) (← links)
- Mathematical modeling of tumor-immune cell interactions (Q1739240) (← links)
- A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy (Q1758078) (← links)
- A mathematical model of the effector cell response to cancer (Q1765055) (← links)
- Periodic and chaotic dynamics in a map-based model of tumor-immune interaction (Q1790827) (← links)
- Cells behaving badly: A theoretical model for the fas/FasL system in tumour immunology (Q1866972) (← links)
- A mathematical model of cancer treatment by immunotherapy (Q1976148) (← links)
- A mathematical model of cell-mediated immune response to tumor (Q1980070) (← links)
- Tumor clearance analysis on a cancer chemo-immunotherapy mathematical model (Q2008266) (← links)
- Nonlinear dynamics in tumor-immune system interaction models with delays (Q2026624) (← links)
- Mathematical modeling of an immune checkpoint inhibitor and its synergy with an immunostimulant (Q2033441) (← links)
- Modelling the interplay between the CD \(4^+\)/CD \(8^+\) t-cell ratio and the expression of MHC-i in tumours (Q2037063) (← links)
- Complex dynamic behaviors of a tumor-immune system with two delays in tumor actions (Q2081974) (← links)
- Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives (Q2092087) (← links)
- Mathematical modeling for the combination treatment of IFN-\(\gamma\) and anti-PD-1 in cancer immunotherapy (Q2103601) (← links)
- A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies (Q2104157) (← links)
- Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response (Q2115998) (← links)
- Optimal control for cancer treatment mathematical model using Atangana-Baleanu-Caputo fractional derivative (Q2116142) (← links)
- Comparative study for optimal control nonlinear variable-order fractional tumor model (Q2120668) (← links)
- The impact of distributed time delay in a tumor-immune interaction system (Q2128278) (← links)
- Interlocked feedback loops balance the adaptive immune response (Q2130483) (← links)
- Investigating of an immune system-cancer mathematical model with Mittag-Leffler kernel (Q2132893) (← links)
- Analysis of noise-induced phenomena in the nonlinear tumor-immune system (Q2164894) (← links)
- Mathematical modeling approach of cancer immunoediting reveals new insights in targeted-therapy and timing plan of cancer treatment (Q2169640) (← links)
- Mathematical modelling of cancer stem cell-targeted immunotherapy (Q2173873) (← links)
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions (Q2176049) (← links)
- Optimal control of inhibiting tumor, new approach to sufficient \(\varepsilon\)-optimality and numerical computation (Q2194798) (← links)
- Implications of immune-mediated metastatic growth on metastatic dormancy, blow-up, early detection, and treatment (Q2204862) (← links)
- A fractional-order delay differential model with optimal control for cancer treatment based on synergy between anti-angiogenic and immune cell therapies (Q2206325) (← links)
- Global dynamics of a breast cancer competition model (Q2210359) (← links)
- Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy (Q2224757) (← links)
- Optimal control of variable-order fractional model for delay cancer treatments (Q2245845) (← links)